Crosstalk between Gut Microbiota and the Central Nervous System in Multiple Sclerosis: Strengths, Weaknesses, Opportunities and Threats Analysis of the Use of An Experimental Model

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|16|9|971-973

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.16, Iss.9, 2018-01, pp. : 971-973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation in the central nervous system in multiple sclerosis: The role of chemokines and their receptors

By Simpson Julie E.   Woodroofe M. Nicola  

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 23-33

VSP

Access to resources Recommend Favorite

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-12 ,pp. : 667-675

Bentham Science Publishers

Access to resources Recommend Favorite

Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system

By Zhou Chunkui   Zhang Beilin   Yang Yi   Zhang Hongliang  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1381-1382

Informa Healthcare

Access to resources Recommend Favorite

IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System

By  

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1882-1893

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of the Applicability and Use of Lipinski`s Rule for Central Nervous System Drugs

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 10, 2016-12 ,pp. : 999-1006

Bentham Science Publishers

Access to resources Recommend Favorite